DION GALLANT: Open Payments
NPI 1730195439 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 25 payments from 13 companies in 2025. Trend: 2023 $444 · 2024 $739 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $161 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Amgen Inc. | 2 | $41 |
| Lundbeck LLC | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| Astellas Pharma US Inc | 1 | $33 |
| CooperSurgical, Inc. | 1 | $22 |
| KYOWA KIRIN, INC. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: REXULTI, EVENITY, FARXIGA, Veozah, Rybelsus, KISUNLA, Paragard T 380A, CRYSVITA.
Industry payments across NM — which companies pay providers there.
